Kayesh Mohammad Enamul Hoque, Ezzikouri Sayeh, Chi Haiying, Sanada Takahiro, Yamamoto Naoki, Kitab Bouchra, Haraguchi Takumi, Matsuyama Rika, Nkogue Chimène Nze, Hatai Hitoshi, Miyoshi Noriaki, Murakami Shuko, Tanaka Yasuhito, Takano Jun-Ichiro, Shiogama Yumiko, Yasutomi Yasuhiro, Kohara Michinori, Tsukiyama-Kohara Kyoko
Department of Pathological and Preventive Veterinary Science, The United Graduate School of Veterinary Science, Yamaguchi University, Yamaguchi, Japan; Laboratory of Animal Hygiene, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.
Transboundary Animal Diseases Centre, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan; Virology Unit, Viral Hepatitis Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.
Virus Res. 2017 Jun 2;237:47-57. doi: 10.1016/j.virusres.2017.05.013. Epub 2017 May 25.
To date, the chimpanzee has been used as the natural infection model for hepatitis B virus (HBV). However, as this model is very costly and difficult to use because of ethical and animal welfare issues, we aimed to establish the tupaia (Tupaia belangeri) as a new model for HBV infection and characterized its intrahepatic innate immune response upon HBV infection. First, we compared the propagation of HBV genotypes A2 and C in vivo in tupaia hepatocytes. At 8-10days post infection (dpi), the level of HBV-A2 propagation in the tupaia liver was found to be higher than that of HBV-C. Abnormal architecture of liver cell cords and mitotic figures were also observed at 8 dpi with HBV-A2. Moreover, we found that HBV-A2 established chronic infection in some tupaias. We then aimed to characterize the intrahepatic innate immune response in this model. First, we infected six tupaias with HBV-A2 (strains JP1 and JP4). At 28 dpi, intrahepatic HBV-DNA and serum hepatitis B surface antigens (HBsAg) were detected in all tupaias. The levels of interferon (IFN)-β were found to be significantly suppressed in the three tupaias infected with HBV A2_JP4, while no significant change was observed in the three infected with HBV A2_JP1. Expression of toll-like receptor (TLR) 1 was suppressed, while that of TLR3 and TLR9 were induced, in HBV A2_JP1-infected tupaias. Expression of TLR8 was induced in all tupaias. Next, we infected nine tupaias with HBV-A2 (JP1, JP2, and JP4), and characterized the infected animals after 31 weeks. Serum HBsAg levels were detected at 31 weeks post-infection (wpi) and IFN-β was found to be significantly suppressed in all tupaias. TLR3 was not induced, except in tupaia #93 and #96. Suppression of TLR9 was observed in all tupaias, except tupaia #93. Also, we investigated the expression levels of cyclic GMP-AMP synthase, which was found to be induced in all tupaias at 28 dpi and in four tupaias at 31 wpi. Additionally, we evaluated the expression levels of sodium-taurocholate cotransporting polypeptide, which was found to be suppressed during chronic HBV infection. Thus, the tupaia infection model of HBV clearly indicated the suppression of IFN-β at 31 wpi, which might have contributed to the establishment of chronic HBV infection.
迄今为止,黑猩猩一直被用作乙型肝炎病毒(HBV)的自然感染模型。然而,由于伦理和动物福利问题,该模型成本高昂且难以使用,因此我们旨在建立树鼩(Tupaia belangeri)作为HBV感染的新模型,并对其感染HBV后的肝内固有免疫反应进行表征。首先,我们比较了HBV基因型A2和C在树鼩肝细胞中的体内传播情况。在感染后8 - 10天(dpi),发现树鼩肝脏中HBV - A2的传播水平高于HBV - C。在感染HBV - A2的8 dpi时,还观察到肝细胞索结构异常和有丝分裂象。此外,我们发现HBV - A2在一些树鼩中建立了慢性感染。然后,我们旨在表征该模型中的肝内固有免疫反应。首先,我们用HBV - A2(菌株JP1和JP4)感染了6只树鼩。在28 dpi时,所有树鼩均检测到肝内HBV - DNA和血清乙型肝炎表面抗原(HBsAg)。在感染HBV A2_JP4的3只树鼩中,干扰素(IFN)-β水平被显著抑制,而在感染HBV A2_JP1的3只树鼩中未观察到显著变化。在感染HBV A2_JP1的树鼩中,Toll样受体(TLR)1的表达受到抑制,而TLR3和TLR9的表达被诱导。在所有树鼩中TLR8的表达均被诱导。接下来,我们用HBV - A2(JP1、JP2和JP4)感染了9只树鼩,并在31周后对感染动物进行表征。在感染后31周(wpi)检测血清HBsAg水平,发现所有树鼩中IFN -β均被显著抑制。除树鼩#93和#96外,TLR3未被诱导。除树鼩#93外,在所有树鼩中均观察到TLR9的抑制。此外,我们研究了环磷酸鸟苷 - 腺苷酸合酶的表达水平,发现在28 dpi时所有树鼩中该酶均被诱导,在31 wpi时4只树鼩中被诱导。另外,我们评估了牛磺胆酸钠共转运多肽的表达水平,发现在慢性HBV感染期间其表达受到抑制。因此,HBV的树鼩感染模型清楚地表明在31 wpi时IFN -β受到抑制,这可能有助于慢性HBV感染的建立。